Cohance Lifesciences Ltd (NSE: COHANCE) climbed 13.0% to Rs 457.80 on Tuesday, 23 June 2026, on volume far above its usual pace (about 73.1 times its recent average).
The move at a glance
- Day change: +12.97% to Rs 457.80
- The stock is about 59% below its 52-week high of Rs 1,121 and 72% above its 52-week low of Rs 267.
- One-year return: -53%
- Today's volume was roughly 73.1 times its recent daily average.
Latest reported financials
| Period | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q4 FY26 | 617 | 8.3 |
| FY26 (full year) | 2,269 | 150.1 |
In Q4 FY26, the company reported revenue of Rs 617 Cr and net profit of Rs 8.3 Cr.
What is behind the move
The standout signal today is volume: the stock changed hands at about 73.1 times its recent daily average, which usually points to a sharp rise in interest from traders. No major regulatory filing was disclosed by the company today on the exchanges, so the rise appears driven by trading activity and buying momentum rather than a fresh company announcement.
Key ratios
P/E 143.0, ROE 3.1%, Debt/Equity 0.04, Promoter holding 57.5%.
--- This article is for educational purposes only and is not investment advice. The figures above are drawn from company filings and exchange data and may contain errors, restatements or timing differences, so please verify against the primary source before relying on them. Stocks Sena is not a SEBI-registered investment adviser.